the two co-founders of hepalink are both senior experts in biosaccharide chemistry, and have in-depth understanding of the significant role of biosaccharide chemistry in immunoregulation. immunological imbalances are the leading cause of cardiovascular disease and tumor formation, and the clinical demand for these two major diseases are left unmet.